Iracema Leroi, Zoe Simkin, Emma Hooper, Lucas Wolski, Harvey Abrams, Christopher J Armitage, Elizabeth Camacho, Anna Pavlina Charalambous, Fideline Collin, Fofi Constantinidou, Piers Dawes, Rachel Elliott, Sue Falkingham, Eric Frison, Mark Hann, Catherine Helmer, Ines Himmelsbach, Hannah Hussain, Sarah Marié, Susana Montecelo, Chryssoula Thodi, Wai Kent Yeung. Impact of an intervention to support hearing and vision in dementia: The SENSE-Cog Field Trial. 2019. International Journal of Geriatric Psychiatry. 35. 348-357.
Edouard Lhomme, Camara Modet, Augustin Augier, Sylvain Faye, Tienhan Sandrine Dabakuyo-Yonli, Claire Levy-Marchal, Eric D’Ortenzio, Yazdan Yazdanpanah, Geneviève Chêne, Abdoul Habib Beavogui, Laura Richert & the PREVAC study team. Enrolling study personnel in Ebola Vaccine trials: From Guidelines to practice in a non-epidemic context. 2019. Trials. 20. 422.
Hooper E, Simkin Z, Abrams H, Camacho E, Charalambous A, Collin F, Constantinidou F, Dawes P, Elliott R, Falkingham S, Frison E, Hann M, Helmer C, Himmelsbach I, Hussain H, Marié S, Montecelo S, Reeves D, Regan J, Thodi C, Wolski L, and Leroi I. Feasibility of an Intervention to Support Hearing and Vision in Dementia: The SENSE-Cog Field Trial. 2019. Journal of the American Geriatrics Society. 67. 1472-1477.
Moore C, Stöhr W, Crook A, Richert L, Leliévre JD, Pantaleo G, García F, Vella S, Lévy Y, Thiébaut R, McCormack S. Multi-arm multi-stage randomised controlled trials for evaluating therapeutic HIV cure interventions. 2019. Lancet HIV. 6. e334-e340.
Regan J, Frison E, Collin F, Dawes P, Hann M, Himmelsbach I, Hooper E, Reeves D, Simkin Z, Thodi C, Yang F, Leroi I and for the SENSE-Cog Trial Development Team. Individualised sensory intervention to improve quality of life in people with dementia and their companions (SENSE-Cog trial): study protocol for a randomised controlled trial. 2019. Trials. 20. 80.
Lutz A, Klimecki O, Collette F, Poisnel G, Arenaza-Urquijo E, Marchant N, De La Sayette V, Rauchs G, Salmon E, Vuilleumier P, Frison E, Vivien D, Chetelat G, and the Medit-Ageing Research Group. The Age-Well observational study on expert meditators in the Medit-Ageing European project. 2018. Alzheimer’s & Dementia. 4. 756-764.
Marchant N, Barnhofer T, Klimecki O, Poisnel G, Lutz A, Arenaza-Urquijo E, Collette F, Wirth M, Schild AK, Coll-Padros N, Reyrolle L, Horney D, Krolak-Salmon P, Molinuevo JL, Walker Z, Maillard A, Frison E, Jessen F, Chetelat G, the SCD-WELL Medit-Ageing Research Group. The SCD-Well randomized controlled trial: Effects of a mindfulness-based intervention versus health education on mental health in patients with subjective cognitive decline (SCD). 2018. Alzheimer’s & Dementia. 4. 737-745.
Poisnel G, Arenaza-Urquijo E, Collette F, Klimecki O, Marchant N, Wirth M, De La Sayette V, Rauchs G, Salmon E, Vuilleumier P, Frison E, Maillard A, Vivien D, Lutz A, Chetelat G, the Medit-Ageing Research Group. The Age-Well randomized controlled trial of the Medit-Ageing European project: Effect of meditation or foreign language training on brain and mental health in older adults. 2018. Alzheimer’s & Dementia. 4. 714-723.
Lise Gross, Edouard Lhomme, Chloé Pasin, Laura Richert, Rodolphe Thiebaut. Ebola vaccine development: Systematic review of pre-clinical and clinical studies, and meta-analysis of determinants of antibody response variability after vaccination. 2018. International Journal of Infectious diseases. 74. 83-96.
